Published on 27 Feb 2024 on Zacks via Yahoo Finance
Here's Why Investors Should Retain STERIS (STE) Stock for Now
STERIS plc STE is well-poised to progress in the coming quarters, backed by the consistent recovery of healthcare procedures and the easing of supply-chain issues. However, macroeconomic constraints challenge STERIS’ operations, while competitive disadvantages are a concern.
In the past year, shares of this Zacks Rank #3 (Hold) company have rallied 25.5% compared with the industry’s 11.3% increase and the S&P 500’s 31.2% rise.
The renowned provider of infection prevention and other procedural products and services has a market capitalization of $23.09 billion. The company has an earnings yield of 3.68% compared with the industry’s -4.83%. In the trailing four quarters, STE delivered an average earnings surprise of 3.96%.